What is the Varicella Attenuated Live Vaccine Market growth?
The Global Varicella Attenuated Live Vaccine Market is expected to grow at a CAGR of 5% during the forecast period (2024-2031).
Who are the key players in Varicella Attenuated Live Vaccine Market?
Key players are Bio-Med Pvt. Limited, GlaxoSmithKline PLC, GC Pharma (Green Cross Holdings), Novo Medi Sciences Pvt. Ltd., Emcure Pharmaceuticals Limited, Sanofi SA, Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, and Takeda Pharmaceutical Company Limited.